In what some are calling a boost for the pharmaceutical industry, the New Jersey Supreme Court dismissed hundreds of lawsuits claiming a Roche (RHHBY) drug caused a serious side effect because the company had not properly warned about potential harm. And in doing so, the court reaffirmed a state product liability law that drug makers rely on to defend themselves, but has caused disagreement in lower courts.

At the center of the litigation was the Accutane acne medication, which was alleged in more than 500 lawsuits to have caused inflammatory bowel disease. Roche withdrew the drug nearly a decade ago as generic versions began entering the market, although the company has been dogged by lawsuits claiming the pill was responsible for various maladies, including Crohn’s disease and depression.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy